Company · CIK 0001826457
Monte Rosa Therapeutics, Inc.
GLUESearch this company’s filings
Search features10 guest searches · Free accounts get 10 a day · No credit card
Market data
Price
$10.30−$0.02 (−0.194%)
GLUE · Last trade
- Prev close
- $10.32
- Range (29d)
- $9.87 – $14.32
On the record
Recent filings
- 8-KGLUECurrent report0001193125-26-409833 · 21.7 MBSEC(opens sec.gov)
- 8-KGLUECurrent report0001193125-26-384360 · 246.4 KBSEC(opens sec.gov)
- SCHEDULE 13G/AGLUEMonte Rosa Therapeutics, Inc.0000919574-26-005533 · 16.4 KBSEC(opens sec.gov)
- SCHEDULE 13GGLUEMonte Rosa Therapeutics, Inc.0000902664-26-003506 · 15.1 KBSEC(opens sec.gov)
- 10-QGLUEQuarterly update0001193125-26-336711 · 10.8 MBSEC(opens sec.gov)
- 8-KGLUECurrent report0001193125-26-336681 · 499.8 KBSEC(opens sec.gov)
- 8-KGLUECurrent report0001193125-26-267465 · 188.3 KBSEC(opens sec.gov)
- 10-QGLUEQuarterly update0001193125-26-210358 · 9.2 MBSEC(opens sec.gov)
- 8-KGLUECurrent report0001193125-26-210298 · 453.2 KBSEC(opens sec.gov)
- 10-KGLUEAnnual report0001193125-26-109360 · 35.8 MBSEC(opens sec.gov)
Insiders
- BASKETT FOREST10% Owner
- Behbahani AliDirector
- Blackwell KimberlyDirector
- Bolzon Bradley J PhDDirector, 10% Owner
- Bowen MatthewPrincipal Accounting Officer
- Castle John C.Chief Data Scientist
- Champoux JenniferChief Operating Officer
- Chang Carmen10% Owner
- Chen Bihua10% Owner
- Cormorant Asset Management, LPFormer 10% Owner
Tickers
Addresses
business
321 HARRISON AVENUE SUITE 900
BOSTON, MA, 02118
mailing
321 HARRISON AVENUE SUITE 900
BOSTON, MA, 02118
Former names
- Monte Rosa Therapeutics, Inc.2026-10-06
Same industry
Related Biological Products, (No Diagnostic Substances) companies
- TBIO-TECHNE CorpTECH
- AAERIE PHARMACEUTICALS INC
- CCellular Biomedicine Group, Inc.
- TTourmaline Bio, Inc.TRML
- NNKGen Biotech, Inc.
- TTevogen Inc.TVGN
- AAttovia Therapeutics, Inc.ATTO
View all Biological Products, (No Diagnostic Substances) companies